News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

 

GT Medical Technologies Announces FDA Clearance of Expanded Indication for GammaTile Therapy

Al's Comment:

[Correction added 1/30/2020] THe 10 month figure is for all brain tumors. GBM added 4 months which is still very good!]

 

 GammaTile is now available for newly diagnosed patients. They reported that it adds 10 months to the average time to progression, which is a major increase with little downside. These are wafers implanted at the time of surgery that deliver radiation to the tumor bed.  We have an interview with one of the doctors who created it at https://virtualtrials.com/video2019.cfm?video=201905


Posted on: 01/27/2020

GT Medical Technologies Announces FDA Clearance of Expanded Indication for GammaTile Therapy

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740